FDA Approval
Showing 1 of 1 results
FDA Approval of Islet Cell Transplant Marks Milestone for UH’s Leading Endocrinologist
Innovations in Diabetes & Metabolic Care | Fall 2024 In 2023, the U.S. Food and Drug Administration (FDA) approved Lantidra™ (donislecel), a breakthrough allogeneic (donor) pancreatic islet cellular therapy for individuals with Type 1 diabetes...
Results are loading...